 CAMBRIDGE, Mass., Sept. 22, 2022 GLOBE NEWSWIRE -- Generation Bio Co. Nasdaq: GBIO, a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 Jefferies Cell Genetic Medicine Summit on Thursday, September 29th at 10:30 a.m. ET in New York. 